Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
1
Total Settlement
$0
21-1657 • July 23, 2019
Class Period Start
March 2, 2017
Class Period End
February 22, 2019
PSLRA Deadline
September 23, 2019
Case Allegations
10b5 + Sec11
10b-5 Statutes of Repose
Mar 2, 2020
Sec11 Statutes of Repose
Apr 28, 2020
Country
United States
Court
Federal Court
Aug 5, 2022
Ruling on Appeal - Closed
Aug 24, 2021
On Appeal
Jul 21, 2021
Motion to Dismiss Granted
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Nov 2, 2020
Motion to Dismiss
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Oct 22, 2020
Second Amended Complaint
A new complaint has been filed on behalf of certain investors in Karyopharm Therapeutics Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
TOP
